4.5 Article

Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline

Journal

BRAIN RESEARCH
Volume 1032, Issue 1-2, Pages 11-22

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2004.10.043

Keywords

neuronal progenitor cell; subependymal zone; adult brain; transplantation

Categories

Funding

  1. NCI NIH HHS [P30CA16059] Funding Source: Medline
  2. NINDS NIH HHS [F31NS42420, F31 NS042420-01, F31 NS042420, F31 NS042420-03, F31 NS042420-04, F31 NS042420-02] Funding Source: Medline

Ask authors/readers for more resources

Neuronal progenitor cells (NPCs) residing in the adult subependymal zone (SEZ) are a potential source of expandable cells for autologous transplantation to treat Parkinson's Disease and other types of brain injury. We have previously demonstrated the capacity of transplanted adult SEZ NPCs for heterotypic differentiation in the hippocampus. To further characterize the therapeutic potential of these cells, NPCs expanded from the adult rat SEZ were grafted to the striatum of normal and 6-OHDA lesioned adult rats. Grafted cells were assessed for neuronal differentiation, and lesioned animals were tested for amphetamine-induced rotational asymmetry. In addition, the effect of inducing differentiation in vitro prior to transplantation was assessed. Although grafted cells survived after 2 weeks in all animals, neither striatal deafferentation nor in vitro induction of differentiation resulted in significant neuronal differentiation of transplanted cells. Grafts, however, did produce a behavioral effect. While sham animals exhibited increased rotational behavior (+67%) from 2 to 4 weeks post-lesioning, grafted animals did not (-21%). Grafted cells continued to express nestin at the survival time point, and dopamine transporter (DAT) immunoreactivity was restored in the graft body. These results suggest that although neither the normal nor the deafferented striatum alone support the neuronal differentiation of transplanted adult SEZ NPCs, grafts maintaining a progenitor phenotype may produce a therapeutic benefit. (C) 2004 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available